

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.34162658 |
| 2 | protein maturation by protein folding (GO:0022417) | 4.05928995 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.00971812 |
| 4 | response to gravity (GO:0009629) | 3.86564516 |
| 5 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.79215950 |
| 6 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.79215950 |
| 7 | positive regulation of TOR signaling (GO:0032008) | 3.71099870 |
| 8 | glutamate secretion (GO:0014047) | 3.69504427 |
| 9 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.66875167 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.52154429 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.48262668 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 3.40210005 |
| 13 | positive regulation of actin filament depolymerization (GO:0030836) | 3.33756247 |
| 14 | GDP-mannose metabolic process (GO:0019673) | 3.27213416 |
| 15 | transferrin transport (GO:0033572) | 3.26297851 |
| 16 | phagosome maturation (GO:0090382) | 3.25489747 |
| 17 | protein complex biogenesis (GO:0070271) | 3.23724190 |
| 18 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10422778 |
| 19 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.08474743 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02862437 |
| 21 | trivalent inorganic cation transport (GO:0072512) | 3.02207768 |
| 22 | ferric iron transport (GO:0015682) | 3.02207768 |
| 23 | platelet dense granule organization (GO:0060155) | 2.97923546 |
| 24 | regulation of autophagic vacuole assembly (GO:2000785) | 2.93612895 |
| 25 | amino sugar catabolic process (GO:0046348) | 2.90815430 |
| 26 | glucosamine-containing compound catabolic process (GO:1901072) | 2.89825656 |
| 27 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.86540405 |
| 28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82418001 |
| 29 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82418001 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82418001 |
| 31 | positive regulation of neurotransmitter transport (GO:0051590) | 2.73473289 |
| 32 | positive regulation of mitochondrial fission (GO:0090141) | 2.72966441 |
| 33 | mannosylation (GO:0097502) | 2.72772428 |
| 34 | negative regulation of cation channel activity (GO:2001258) | 2.71496326 |
| 35 | C-terminal protein lipidation (GO:0006501) | 2.69910463 |
| 36 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.69453509 |
| 37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.67625810 |
| 38 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.67111419 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67070019 |
| 40 | neurotransmitter secretion (GO:0007269) | 2.65696574 |
| 41 | respiratory electron transport chain (GO:0022904) | 2.65004014 |
| 42 | regulation of vacuole organization (GO:0044088) | 2.63547121 |
| 43 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.62799124 |
| 44 | electron transport chain (GO:0022900) | 2.62730433 |
| 45 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.61596240 |
| 46 | inositol phosphate catabolic process (GO:0071545) | 2.61525589 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.61446481 |
| 48 | melanin biosynthetic process (GO:0042438) | 2.60387533 |
| 49 | metallo-sulfur cluster assembly (GO:0031163) | 2.59976523 |
| 50 | iron-sulfur cluster assembly (GO:0016226) | 2.59976523 |
| 51 | protein insertion into membrane (GO:0051205) | 2.59594424 |
| 52 | actin nucleation (GO:0045010) | 2.57491118 |
| 53 | inositol phosphate dephosphorylation (GO:0046855) | 2.52844678 |
| 54 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.52844678 |
| 55 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.49798997 |
| 56 | cytochrome complex assembly (GO:0017004) | 2.41373463 |
| 57 | mitotic nuclear envelope reassembly (GO:0007084) | 2.41338665 |
| 58 | nuclear envelope reassembly (GO:0031468) | 2.41338665 |
| 59 | regulation of protein kinase A signaling (GO:0010738) | 2.40576908 |
| 60 | sequestering of actin monomers (GO:0042989) | 2.39906503 |
| 61 | adenosine receptor signaling pathway (GO:0001973) | 2.37688830 |
| 62 | type B pancreatic cell proliferation (GO:0044342) | 2.36751523 |
| 63 | respiratory chain complex IV assembly (GO:0008535) | 2.35708615 |
| 64 | regulation of synaptic vesicle transport (GO:1902803) | 2.33733624 |
| 65 | hydrogen ion transmembrane transport (GO:1902600) | 2.32790811 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.31756770 |
| 67 | glycosphingolipid biosynthetic process (GO:0006688) | 2.31482028 |
| 68 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.31225202 |
| 69 | extracellular fibril organization (GO:0043206) | 2.29961675 |
| 70 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.29894142 |
| 71 | cellular response to zinc ion (GO:0071294) | 2.29139960 |
| 72 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.26109964 |
| 73 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.26109964 |
| 74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.25423545 |
| 75 | pyrimidine nucleoside salvage (GO:0043097) | 2.25215505 |
| 76 | pyrimidine-containing compound salvage (GO:0008655) | 2.25215505 |
| 77 | C-terminal protein amino acid modification (GO:0018410) | 2.23525523 |
| 78 | cellular potassium ion homeostasis (GO:0030007) | 2.23187240 |
| 79 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.20236980 |
| 80 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.19785530 |
| 81 | gamma-aminobutyric acid transport (GO:0015812) | 2.18918604 |
| 82 | fibril organization (GO:0097435) | 2.18852562 |
| 83 | proton transport (GO:0015992) | 2.18348912 |
| 84 | DNA deamination (GO:0045006) | 2.17464746 |
| 85 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.16365187 |
| 86 | hydrogen transport (GO:0006818) | 2.16063478 |
| 87 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.15757516 |
| 88 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.15757516 |
| 89 | GPI anchor biosynthetic process (GO:0006506) | 2.15747466 |
| 90 | viral protein processing (GO:0019082) | 2.14190883 |
| 91 | virion assembly (GO:0019068) | 2.10977805 |
| 92 | endosome to melanosome transport (GO:0035646) | 2.10959059 |
| 93 | endosome to pigment granule transport (GO:0043485) | 2.10959059 |
| 94 | ATP synthesis coupled proton transport (GO:0015986) | 2.10742460 |
| 95 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.10742460 |
| 96 | response to interferon-beta (GO:0035456) | 2.10308409 |
| 97 | melanin metabolic process (GO:0006582) | 2.09120126 |
| 98 | glycolipid biosynthetic process (GO:0009247) | 2.07873294 |
| 99 | adaptation of signaling pathway (GO:0023058) | 2.07509602 |
| 100 | synaptic vesicle endocytosis (GO:0048488) | 2.06204017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.90189946 |
| 2 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.80711399 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.73695082 |
| 4 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.32594888 |
| 5 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.26506540 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.25817184 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25602625 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21383275 |
| 9 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.15714569 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05522433 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.04801375 |
| 12 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.02000667 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.97429265 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97071809 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.95075032 |
| 16 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.91328900 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90274966 |
| 18 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89650589 |
| 19 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.88710382 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87368149 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87249705 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81184632 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 1.79967010 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75467173 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69716043 |
| 26 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.68225872 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.65665603 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63827727 |
| 29 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.57370290 |
| 30 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.52701097 |
| 31 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.52541517 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51714750 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51629339 |
| 34 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50893348 |
| 35 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.50702214 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49208598 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48422123 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48360630 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46239992 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43243220 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43144925 |
| 42 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.40133112 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40048001 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39761246 |
| 45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39749421 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38374018 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37705102 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.36820008 |
| 49 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35285893 |
| 50 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34068345 |
| 51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33951203 |
| 52 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.33174520 |
| 53 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30428080 |
| 54 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29316784 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.27672191 |
| 56 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.26192553 |
| 57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.24829896 |
| 58 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24697481 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23767569 |
| 60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.23146231 |
| 61 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22815568 |
| 62 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.21657046 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.21194954 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18669121 |
| 65 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18378581 |
| 66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17367054 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16273142 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15530127 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15056138 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14655377 |
| 71 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.13043031 |
| 72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11948316 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11621724 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11194203 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11057382 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10661961 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10000360 |
| 78 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09412947 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.09206304 |
| 80 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07520146 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06240696 |
| 82 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06063400 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05376172 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 1.04975942 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04576548 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04267691 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03590279 |
| 88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03544958 |
| 89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02576326 |
| 90 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.99336821 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98239735 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.97966325 |
| 93 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.97715961 |
| 94 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97650462 |
| 95 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97013697 |
| 96 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96267023 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96190517 |
| 98 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96099630 |
| 99 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94861188 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94743553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.39747711 |
| 2 | MP0005423_abnormal_somatic_nervous | 2.85492367 |
| 3 | MP0003880_abnormal_central_pattern | 2.79543536 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.60724008 |
| 5 | MP0005171_absent_coat_pigmentation | 2.58230831 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.45044049 |
| 7 | MP0009046_muscle_twitch | 2.44524293 |
| 8 | MP0001905_abnormal_dopamine_level | 2.28034358 |
| 9 | MP0002064_seizures | 2.24817956 |
| 10 | MP0004270_analgesia | 2.19868762 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.16967525 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.12964443 |
| 13 | MP0009745_abnormal_behavioral_response | 2.06328571 |
| 14 | MP0002272_abnormal_nervous_system | 1.97424366 |
| 15 | MP0002736_abnormal_nociception_after | 1.96532605 |
| 16 | MP0009840_abnormal_foam_cell | 1.92876364 |
| 17 | MP0003075_altered_response_to | 1.75678597 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.75664850 |
| 19 | MP0003329_amyloid_beta_deposits | 1.73730307 |
| 20 | MP0001970_abnormal_pain_threshold | 1.73557610 |
| 21 | MP0002063_abnormal_learning/memory/cond | 1.71147078 |
| 22 | MP0004510_myositis | 1.70294717 |
| 23 | MP0001502_abnormal_circadian_rhythm | 1.69620630 |
| 24 | MP0001986_abnormal_taste_sensitivity | 1.66930435 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 1.64938166 |
| 26 | MP0000015_abnormal_ear_pigmentation | 1.63355037 |
| 27 | MP0000343_altered_response_to | 1.61022382 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.58739276 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.57062962 |
| 30 | MP0006082_CNS_inflammation | 1.55147340 |
| 31 | MP0001542_abnormal_bone_strength | 1.51930573 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.50453549 |
| 33 | MP0001486_abnormal_startle_reflex | 1.40538646 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.40100624 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.37992474 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.37450387 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.37330722 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.37187414 |
| 39 | MP0003879_abnormal_hair_cell | 1.36588497 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.30115657 |
| 41 | MP0002822_catalepsy | 1.29738544 |
| 42 | MP0003123_paternal_imprinting | 1.27595413 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.27354506 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.26457023 |
| 45 | MP0003011_delayed_dark_adaptation | 1.24684361 |
| 46 | MP0000750_abnormal_muscle_regeneration | 1.24414667 |
| 47 | MP0000604_amyloidosis | 1.23979172 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.23347202 |
| 49 | MP0000920_abnormal_myelination | 1.22774769 |
| 50 | MP0003136_yellow_coat_color | 1.21413033 |
| 51 | MP0003633_abnormal_nervous_system | 1.20223501 |
| 52 | MP0003436_decreased_susceptibility_to | 1.19371052 |
| 53 | MP0001756_abnormal_urination | 1.17450108 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.16813831 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.16610939 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.14336873 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.11706369 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.05848484 |
| 59 | MP0002229_neurodegeneration | 1.04552230 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.04444913 |
| 61 | MP0005671_abnormal_response_to | 1.04069184 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.04031482 |
| 63 | MP0008569_lethality_at_weaning | 1.03048306 |
| 64 | MP0005535_abnormal_body_temperature | 1.01809559 |
| 65 | MP0003195_calcinosis | 1.01043700 |
| 66 | MP0008874_decreased_physiological_sensi | 0.98530337 |
| 67 | MP0008260_abnormal_autophagy | 0.98392325 |
| 68 | MP0005464_abnormal_platelet_physiology | 0.98293646 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 0.94780613 |
| 70 | MP0005166_decreased_susceptibility_to | 0.94104234 |
| 71 | MP0005386_behavior/neurological_phenoty | 0.93291759 |
| 72 | MP0004924_abnormal_behavior | 0.93291759 |
| 73 | MP0003690_abnormal_glial_cell | 0.92905614 |
| 74 | MP0009785_altered_susceptibility_to | 0.92398853 |
| 75 | MP0004142_abnormal_muscle_tone | 0.91645100 |
| 76 | MP0003724_increased_susceptibility_to | 0.91247309 |
| 77 | MP0002090_abnormal_vision | 0.90701781 |
| 78 | MP0005000_abnormal_immune_tolerance | 0.89728241 |
| 79 | MP0001984_abnormal_olfaction | 0.89028278 |
| 80 | MP0003631_nervous_system_phenotype | 0.88228325 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87883656 |
| 82 | MP0005253_abnormal_eye_physiology | 0.87041253 |
| 83 | MP0002066_abnormal_motor_capabilities/c | 0.86909009 |
| 84 | MP0004885_abnormal_endolymph | 0.86789846 |
| 85 | MP0005646_abnormal_pituitary_gland | 0.84825524 |
| 86 | MP0004811_abnormal_neuron_physiology | 0.84036596 |
| 87 | MP0009764_decreased_sensitivity_to | 0.82229165 |
| 88 | MP0005025_abnormal_response_to | 0.81333408 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.80876325 |
| 90 | MP0001529_abnormal_vocalization | 0.79886030 |
| 91 | MP0000639_abnormal_adrenal_gland | 0.78762645 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.78113912 |
| 93 | MP0005332_abnormal_amino_acid | 0.77523479 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.77320688 |
| 95 | MP0005165_increased_susceptibility_to | 0.76968214 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76021640 |
| 97 | MP0002419_abnormal_innate_immunity | 0.75958244 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.75801832 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.74793757 |
| 100 | MP0005083_abnormal_biliary_tract | 0.74309350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90192938 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90192938 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90192938 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.59479568 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.49491693 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.48119262 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.29434195 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.18304227 |
| 9 | Hepatic necrosis (HP:0002605) | 3.17461606 |
| 10 | Progressive macrocephaly (HP:0004481) | 3.01787857 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.98650751 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.98650751 |
| 13 | Myokymia (HP:0002411) | 2.94814276 |
| 14 | Dysostosis multiplex (HP:0000943) | 2.94185924 |
| 15 | Increased CSF lactate (HP:0002490) | 2.87135103 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 2.86182127 |
| 17 | Delusions (HP:0000746) | 2.71611640 |
| 18 | Polyphagia (HP:0002591) | 2.71443259 |
| 19 | Progressive neurologic deterioration (HP:0002344) | 2.70685140 |
| 20 | Mutism (HP:0002300) | 2.67649698 |
| 21 | Retinal dysplasia (HP:0007973) | 2.64077251 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.62252173 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.62252173 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.62252173 |
| 25 | Hand muscle atrophy (HP:0009130) | 2.61348444 |
| 26 | Hypokinesia (HP:0002375) | 2.60034542 |
| 27 | Acute encephalopathy (HP:0006846) | 2.57928376 |
| 28 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.54317551 |
| 29 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54110596 |
| 30 | Increased hepatocellular lipid droplets (HP:0006565) | 2.52656280 |
| 31 | Cerebral hypomyelination (HP:0006808) | 2.45438761 |
| 32 | Abnormality of binocular vision (HP:0011514) | 2.45398998 |
| 33 | Diplopia (HP:0000651) | 2.45398998 |
| 34 | Upper limb muscle weakness (HP:0003484) | 2.45203804 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.45022066 |
| 36 | Prolonged neonatal jaundice (HP:0006579) | 2.40455312 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.33702547 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33702547 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.33102306 |
| 40 | Retinal atrophy (HP:0001105) | 2.31065884 |
| 41 | Emotional lability (HP:0000712) | 2.30549462 |
| 42 | Neurofibrillary tangles (HP:0002185) | 2.29114131 |
| 43 | Tongue fasciculations (HP:0001308) | 2.28642218 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27198349 |
| 45 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.26378039 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24378143 |
| 47 | Loss of speech (HP:0002371) | 2.23506941 |
| 48 | Testicular atrophy (HP:0000029) | 2.22839152 |
| 49 | Neuronal loss in central nervous system (HP:0002529) | 2.22461479 |
| 50 | Hemiparesis (HP:0001269) | 2.21805581 |
| 51 | Increased muscle lipid content (HP:0009058) | 2.21354057 |
| 52 | Axonal loss (HP:0003447) | 2.20217722 |
| 53 | Exertional dyspnea (HP:0002875) | 2.20208365 |
| 54 | Abnormal gallbladder physiology (HP:0012438) | 2.16988067 |
| 55 | Cholecystitis (HP:0001082) | 2.16988067 |
| 56 | Action tremor (HP:0002345) | 2.14804697 |
| 57 | Upper limb amyotrophy (HP:0009129) | 2.13759873 |
| 58 | Distal upper limb amyotrophy (HP:0007149) | 2.13759873 |
| 59 | Ketoacidosis (HP:0001993) | 2.12210010 |
| 60 | Progressive microcephaly (HP:0000253) | 2.10075195 |
| 61 | Lactic acidosis (HP:0003128) | 2.09352339 |
| 62 | Petechiae (HP:0000967) | 2.08308789 |
| 63 | Respiratory failure (HP:0002878) | 2.07967086 |
| 64 | Diminished movement (HP:0002374) | 2.06945189 |
| 65 | Absent speech (HP:0001344) | 2.06884370 |
| 66 | Visual hallucinations (HP:0002367) | 2.06767391 |
| 67 | Akinesia (HP:0002304) | 2.06497532 |
| 68 | Abnormal eating behavior (HP:0100738) | 2.04126061 |
| 69 | Opisthotonus (HP:0002179) | 2.02525962 |
| 70 | Intention tremor (HP:0002080) | 2.02004227 |
| 71 | Amyloidosis (HP:0011034) | 2.01977511 |
| 72 | Exercise intolerance (HP:0003546) | 2.01782194 |
| 73 | Muscle fibrillation (HP:0010546) | 2.01659930 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.01348739 |
| 75 | Ocular albinism (HP:0001107) | 2.00043409 |
| 76 | Severe muscular hypotonia (HP:0006829) | 1.95203067 |
| 77 | Congenital stationary night blindness (HP:0007642) | 1.93048293 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92790569 |
| 79 | Focal dystonia (HP:0004373) | 1.92128308 |
| 80 | Abnormality of macrophages (HP:0004311) | 1.92018177 |
| 81 | Albinism (HP:0001022) | 1.91682822 |
| 82 | Type I transferrin isoform profile (HP:0003642) | 1.91209783 |
| 83 | Focal motor seizures (HP:0011153) | 1.89160455 |
| 84 | Diminished motivation (HP:0000745) | 1.88379198 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 1.87540288 |
| 86 | Dysautonomia (HP:0002459) | 1.87010409 |
| 87 | Myoclonus (HP:0001336) | 1.86680761 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 1.85706183 |
| 89 | Hyperthyroidism (HP:0000836) | 1.83493991 |
| 90 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83438566 |
| 91 | Epileptic encephalopathy (HP:0200134) | 1.82397205 |
| 92 | Agitation (HP:0000713) | 1.81868813 |
| 93 | Ankle clonus (HP:0011448) | 1.81794551 |
| 94 | Tetraplegia (HP:0002445) | 1.81755185 |
| 95 | Nuclear cataract (HP:0100018) | 1.81068278 |
| 96 | Increased serum lactate (HP:0002151) | 1.80263097 |
| 97 | Adrenal hypoplasia (HP:0000835) | 1.80004078 |
| 98 | Apathy (HP:0000741) | 1.79744461 |
| 99 | Iris hypopigmentation (HP:0007730) | 1.78675256 |
| 100 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77352068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 4.19121595 |
| 2 | TESK2 | 3.74336860 |
| 3 | LIMK1 | 3.63657027 |
| 4 | DAPK2 | 2.46253308 |
| 5 | ARAF | 2.43382194 |
| 6 | PAK6 | 2.21497956 |
| 7 | PIM2 | 2.14099069 |
| 8 | NME2 | 2.06782848 |
| 9 | DAPK1 | 1.97294090 |
| 10 | MAP3K11 | 1.95252443 |
| 11 | GRK5 | 1.94663861 |
| 12 | MAP3K12 | 1.67354451 |
| 13 | MAP2K7 | 1.66684449 |
| 14 | BCKDK | 1.65350250 |
| 15 | LMTK2 | 1.62082371 |
| 16 | CSNK1G3 | 1.61208826 |
| 17 | SIK3 | 1.58287677 |
| 18 | PHKG1 | 1.53628460 |
| 19 | PHKG2 | 1.53628460 |
| 20 | VRK2 | 1.52242687 |
| 21 | PRKD3 | 1.50199029 |
| 22 | STK16 | 1.49437819 |
| 23 | CSNK1G2 | 1.46354992 |
| 24 | TAOK2 | 1.38158082 |
| 25 | TBK1 | 1.37504968 |
| 26 | GRK7 | 1.35312468 |
| 27 | CSNK1A1L | 1.31717725 |
| 28 | EPHA4 | 1.29090671 |
| 29 | MARK1 | 1.28214967 |
| 30 | ABL2 | 1.23504639 |
| 31 | MAP4K2 | 1.21118925 |
| 32 | PINK1 | 1.17247080 |
| 33 | MAPKAPK3 | 1.16378803 |
| 34 | SIK2 | 1.15346288 |
| 35 | NTRK3 | 1.11190062 |
| 36 | MINK1 | 1.07054137 |
| 37 | PTK2B | 1.05982222 |
| 38 | DAPK3 | 1.04864381 |
| 39 | IRAK3 | 1.04706251 |
| 40 | ERN1 | 1.04406501 |
| 41 | PRKD2 | 1.03390692 |
| 42 | PLK2 | 0.98596853 |
| 43 | PAK3 | 0.93108642 |
| 44 | EPHB1 | 0.92792509 |
| 45 | KDR | 0.91652591 |
| 46 | CSNK1G1 | 0.91345413 |
| 47 | FRK | 0.89995840 |
| 48 | MAPK13 | 0.89627539 |
| 49 | ADRBK2 | 0.89457237 |
| 50 | MAP2K6 | 0.87815973 |
| 51 | CAMKK2 | 0.87309717 |
| 52 | MAP3K4 | 0.85072242 |
| 53 | MOS | 0.81504808 |
| 54 | TRIM28 | 0.79611823 |
| 55 | BLK | 0.78766117 |
| 56 | MAP3K3 | 0.78500531 |
| 57 | CDK14 | 0.77079637 |
| 58 | GRK6 | 0.75753550 |
| 59 | PKN1 | 0.74346055 |
| 60 | TNK2 | 0.74273798 |
| 61 | RIPK4 | 0.70987961 |
| 62 | HIPK2 | 0.70620268 |
| 63 | TXK | 0.69719725 |
| 64 | IKBKB | 0.69389681 |
| 65 | PAK1 | 0.69157155 |
| 66 | CAMK2G | 0.68106681 |
| 67 | CCNB1 | 0.68009368 |
| 68 | PRKCG | 0.66615014 |
| 69 | ADRBK1 | 0.65685702 |
| 70 | CDK18 | 0.63879160 |
| 71 | UHMK1 | 0.63388700 |
| 72 | IKBKE | 0.62918488 |
| 73 | IRAK2 | 0.62713504 |
| 74 | PRKCI | 0.62677901 |
| 75 | CAMK2D | 0.62607675 |
| 76 | CDK5 | 0.60907620 |
| 77 | CAMKK1 | 0.60813950 |
| 78 | CDK15 | 0.60536662 |
| 79 | TLK1 | 0.60505899 |
| 80 | ZAP70 | 0.60442929 |
| 81 | MYLK | 0.60055517 |
| 82 | PRKD1 | 0.58785430 |
| 83 | CDK11A | 0.58269275 |
| 84 | STK38 | 0.57224813 |
| 85 | EPHA3 | 0.56360163 |
| 86 | GRK1 | 0.55710754 |
| 87 | AURKA | 0.55029812 |
| 88 | BRAF | 0.53889818 |
| 89 | BMPR2 | 0.53742628 |
| 90 | MAP4K1 | 0.53531110 |
| 91 | CAMK2A | 0.51365682 |
| 92 | TAOK1 | 0.50865720 |
| 93 | FER | 0.50741471 |
| 94 | CDK19 | 0.49467406 |
| 95 | CAMK2B | 0.45224924 |
| 96 | MAP3K1 | 0.43620970 |
| 97 | ILK | 0.42829639 |
| 98 | MARK3 | 0.42506890 |
| 99 | TAOK3 | 0.41105954 |
| 100 | MAPK12 | 0.37607462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.88645346 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.81695821 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.41168086 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.40180540 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.70213134 |
| 6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.61196280 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.55735145 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.36909961 |
| 9 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.26503113 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.24427930 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.22207745 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.15042771 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99327928 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.85893963 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.79122993 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.73404975 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.68785983 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.67531709 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.61509993 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60194800 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53927238 |
| 22 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.53480359 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50074810 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.49827972 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.42210030 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36496311 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.35742587 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.34733404 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26404991 |
| 30 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23327810 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23289585 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.22287493 |
| 33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20903110 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.20484748 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.19492763 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17850773 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16255796 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.15552750 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.14236892 |
| 40 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12804791 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06762163 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06598686 |
| 43 | Endocytosis_Homo sapiens_hsa04144 | 1.03782214 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00460674 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00265704 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94092343 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92791924 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91697460 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 0.90889934 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86194134 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83291924 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.82610333 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80391946 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.79936177 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76406409 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76034235 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72545260 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71212943 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70394944 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68048078 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.67298064 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66386558 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65799506 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65454990 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.61725083 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56315426 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54947050 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52132945 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51522731 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.48440763 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47666392 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.47659266 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47540435 |
| 74 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45045901 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43202232 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38112518 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37578932 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.36635407 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36335690 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.34939094 |
| 81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32405703 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31782923 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31247599 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.31064742 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.30885079 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30846304 |
| 87 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30153606 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29695819 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29432738 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29162289 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28847099 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27521608 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27161644 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.27093576 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | 0.26941320 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26814398 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26783402 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24933071 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24011196 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.23605583 |

